Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07453693 · ClinicalTrials.gov registry record · NA
An Efficacy Study of a Dietary Supplement Drink Mix for Urinary Health Improvement
A NA study of UTI's, sponsored by Bonafide Health.
- Recruiting
- Registry status
- NA
- Development phase
- 210
- Enrollment target
- 1
- Study location
NCT07453693: Recruiting NA study of UTI's, sponsored by Bonafide Health.
NCT07453693 is a NA study of UTI's that is actively recruiting participants, run by Bonafide Health. The registered enrollment target is 210 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07453693, a NA study of UTI's, is actively recruiting participants, sponsored by Bonafide Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 210 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a 6-month, three-arm randomized controlled trial evaluating the efficacy and safety of a dietary supplement drink mix on urinary health outcomes in adult females. Participants will be randomly assigned to one of three study arms and followed for six months to assess changes in urinary health measures.
Primary Outcome
Time (days) to recurrence of clinically suspected UTI
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT FLUSH
Study Locations (1)
New York
- Bonafide Health - Harrison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 210 participants |
| Start Date | 2025-07-07 |
| Est. Completion | 2026-12-15 |
| Phase | NA |
What NCT07453693 shows while recruiting
NCT07453693 is an interventional study that assigns participants to a tested intervention. The registered 210 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).
The record links to 1 condition, with UTI's appearing as the primary indexed condition, and to 1 intervention - of which FLUSH is the first listed.
NCT07453693 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT07453693 about?
NCT07453693 is a clinical study titled "An Efficacy Study of a Dietary Supplement Drink Mix for Urinary Health Improvement". This is a 6-month, three-arm randomized controlled trial evaluating the efficacy and safety of a dietary supplement drink mix on urinary health outcomes in adult females. Participants will be randomly assigned to one of three study arms and followed for six months to assess changes in urinary health...
What is the current status of trial NCT07453693?
This trial is currently recruiting. It is a NA study. The enrollment target is 210 participants. The study started on 2025-07-07. Estimated completion is 2026-12-15.
What conditions does trial NCT07453693 study?
This clinical trial studies the following conditions: UTI's.
What interventions are being tested in trial NCT07453693?
The interventions under investigation include: FLUSH (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07453693?
This trial is sponsored by Bonafide Health, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07453693 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07453693's enrollment target sits among peer trials
210 490th of 2000 higher than 1,505 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02665923 · 210 participants
Gastric Emptying in Neonates and Infants After Formula Feeding
- NCT03322891 · 210 participants · NA
Improving Health Literacy in African-American Prostate Cancer Patients
- NCT03544489 · 210 participants · Phase 2
Effectiveness of Exercise After an ICD
- NCT04408430 · 210 participants · NA
The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI